Mottola Frank sold SUPN
August 25, 2025 · Form 4 insider transaction
Mottola Frank sold 14,000 shares of Supernus Pharmaceuticals, Inc. at $44.51 per share, a transaction worth $623.1K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
14,000
Price
$44.51
Total value
$623.1K
InsiderMottola Frank
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 25, 2025
Filing dateAugust 27, 2025
Shares owned after15,496
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The Reporting Person exercised the options indicated herein and sold the underlying shares prior to the expiration of such options on March 1, 2026.